Empfehlung
3,1
Stark Verkaufen
Composite Score (0–100)
Insider (25%)
0
Keine Insider-Käufe
Institutionell (22,5%)
0
Keine neuen Positionen
Aktivist (12,5%)
0
Kein 13D/13G
Risikofreier Zins (T-Bills): 3,72% (Stand: 28.02.2026)
Score-Verlauf (90 Tage)
Kritische 8-K Meldungen
Stammdaten
Unternehmen
| Name | ARROWHEAD PHARMACEUTICALS, INC. |
|---|---|
| Ticker | ARWR |
| CIK | 0000879407 |
Branche
| SIC-Code | 2834 |
|---|---|
| Beschreibung | Pharmaceutical Preparations |
Wertpapier
| CUSIP | – |
|---|---|
| ISIN | – |
| Typ | Common Stock |
| Titel | ARROWHEAD PHARMACEUTICALS, INC. |
Status
| Zuletzt geprüft | 2026-03-25 00:01:31.196753 |
|---|
Finanzkennzahlen (SEC XBRL)
| Periode | Filing | Umsatz | Nettoergebnis | EPS | Aktiva | Eigenkapital |
|---|---|---|---|---|---|---|
| 2025-09-30 | 10-K | 829,448,000 | -1,631,000 | -0.01 | 1,385,295,000 | 466,052,000 |
| 2018-09-30 | 10-K | 16,142,321 |
Fondsaktivität (letzte 3 Quartale)
Keine Fondsdaten für dieses Unternehmen vorhanden.
Insider-Transaktionen (12 Monate)
| Datum | Insider | Rolle | Typ | Stückzahl | Kurs | Wert (USD) | Δ | Trend |
|---|---|---|---|---|---|---|---|---|
| 2026-03-05 | Hamilton James C | Officer, Chief Medical Officer | Open Market Sale | -10,000 | 64.19 | -641,900.00 | -108,9% | |
| 2026-03-05 | Hamilton James C | Officer, Chief Medical Officer | Open Market Sale | -10,000 | 64.19 | -641,900.00 | -108,9% | |
| 2026-01-05 | Hamilton James C | Officer, Chief Medical Officer | Open Market Sale | -1,200 | 64.49 | -77,388.00 | -13,1% | |
| 2026-01-05 | O'Brien Patrick | Officer, COO | Open Market Sale | -4,368 | 61.20 | -267,321.60 | -45,4% | |
| 2026-01-05 | Hamilton James C | Officer, Chief Medical Officer | Open Market Sale | -309 | 68.00 | -21,012.00 | -3,6% | |
| 2026-01-05 | Hamilton James C | Officer, Chief Medical Officer | Open Market Sale | -437 | 65.97 | -28,828.89 | -4,9% | |
| 2026-01-05 | Hamilton James C | Officer, Chief Medical Officer | Open Market Sale | -1,200 | 64.49 | -77,388.00 | -13,1% | |
| 2026-01-05 | Hamilton James C | Officer, Chief Medical Officer | Open Market Sale | -12,711 | 63.95 | -812,868.45 | -138,0% | |
| 2026-01-05 | Hamilton James C | Officer, Chief Medical Officer | Open Market Sale | -14,792 | 63.01 | -932,043.92 | -158,2% | |
| 2026-01-05 | Hamilton James C | Officer, Chief Medical Officer | Open Market Sale | -6,090 | 62.28 | -379,285.20 | -64,4% | |
| 2026-01-05 | Hamilton James C | Officer, Chief Medical Officer | Open Market Sale | -4,625 | 61.24 | -283,235.00 | -48,1% | |
| 2026-01-05 | Hamilton James C | Officer, Chief Medical Officer | Open Market Sale | -309 | 68.00 | -21,012.00 | -3,6% | |
| 2026-01-05 | Hamilton James C | Officer, Chief Medical Officer | Open Market Sale | -437 | 65.97 | -28,828.89 | -4,9% | |
| 2026-01-05 | Hamilton James C | Officer, Chief Medical Officer | Open Market Sale | -12,711 | 63.95 | -812,868.45 | -138,0% | |
| 2026-01-05 | Hamilton James C | Officer, Chief Medical Officer | Open Market Sale | -14,792 | 63.01 | -932,043.92 | -158,2% | |
| 2026-01-05 | Hamilton James C | Officer, Chief Medical Officer | Open Market Sale | -6,090 | 62.28 | -379,285.20 | -64,4% | |
| 2026-01-05 | Hamilton James C | Officer, Chief Medical Officer | Open Market Sale | -4,625 | 61.24 | -283,235.00 | -48,1% | |
| 2026-01-05 | O'Brien Patrick | Officer, COO | Open Market Sale | -600 | 61.12 | -36,672.00 | -6,2% | |
| 2026-01-05 | O'Brien Patrick | Officer, COO | Open Market Sale | -900 | 62.25 | -56,025.00 | -9,5% | |
| 2026-01-05 | O'Brien Patrick | Officer, COO | Open Market Sale | -5,873 | 62.91 | -369,470.43 | -62,7% | |
| 2026-01-05 | O'Brien Patrick | Officer, COO | Open Market Sale | -2,336 | 64.04 | -149,597.44 | -25,4% | |
| 2026-01-05 | O'Brien Patrick | Officer, COO | Open Market Sale | -46 | 68.00 | -3,128.00 | -0,5% | |
| 2026-01-05 | O'Brien Patrick | Officer, COO | Open Market Sale | -6,164 | 62.23 | -383,585.72 | -65,1% | |
| 2026-01-05 | O'Brien Patrick | Officer, COO | Open Market Sale | -13,451 | 62.96 | -846,874.96 | -143,7% | |
| 2026-01-05 | O'Brien Patrick | Officer, COO | Open Market Sale | -11,842 | 63.84 | -755,993.28 | -128,3% | |
| 2026-01-05 | O'Brien Patrick | Officer, COO | Open Market Sale | -2,700 | 64.44 | -173,988.00 | -29,5% | |
| 2026-01-05 | O'Brien Patrick | Officer, COO | Open Market Sale | -900 | 66.01 | -59,409.00 | -10,1% | |
| 2026-01-05 | O'Brien Patrick | Officer, COO | Open Market Sale | -313 | 68.00 | -21,284.00 | -3,6% | |
| 2026-01-02 | Anzalone Christopher Richard | Director, Officer, Chief Executive Officer | Open Market Sale | -5,771 | 66.39 | -383,136.69 | -65,0% | |
| 2026-01-02 | Anzalone Christopher Richard | Director, Officer, Chief Executive Officer | Open Market Sale | -7,416 | 65.88 | -488,566.08 | -82,9% | |
| 2026-01-02 | Anzalone Christopher Richard | Director, Officer, Chief Executive Officer | Open Market Sale | -5,771 | 66.39 | -383,136.69 | -65,0% | |
| 2026-01-02 | Anzalone Christopher Richard | Director, Officer, Chief Executive Officer | Open Market Sale | -7,416 | 65.88 | -488,566.08 | -82,9% | |
| 2025-12-29 | Anzalone Christopher Richard | Director, Officer, Chief Executive Officer | Open Market Sale | -16,545 | 68.69 | -1,136,476.05 | -192,9% | |
| 2025-12-29 | Anzalone Christopher Richard | Director, Officer, Chief Executive Officer | Open Market Sale | -35,181 | 69.33 | -2,439,098.73 | -414,0% | |
| 2025-12-29 | Anzalone Christopher Richard | Director, Officer, Chief Executive Officer | Open Market Sale | -16,545 | 68.69 | -1,136,476.05 | -192,9% | |
| 2025-12-29 | Anzalone Christopher Richard | Director, Officer, Chief Executive Officer | Open Market Sale | -35,181 | 69.33 | -2,439,098.73 | -414,0% | |
| 2025-12-26 | Ferrari Mauro | Director | Open Market Sale | -7,530 | 70.00 | -527,100.00 | -89,5% | |
| 2025-12-26 | Ferrari Mauro | Director | Open Market Sale | -7,530 | 70.00 | -527,100.00 | -89,5% | |
| 2025-12-22 | Anzalone Christopher Richard | Director, Officer, Chief Executive Officer | Open Market Sale | -2,574 | 68.85 | -177,219.90 | -30,1% | |
| 2025-12-22 | Anzalone Christopher Richard | Director, Officer, Chief Executive Officer | Open Market Sale | -10,012 | 68.33 | -684,119.96 | -116,1% | |
| 2025-12-22 | Anzalone Christopher Richard | Director, Officer, Chief Executive Officer | Open Market Sale | -10,012 | 68.33 | -684,119.96 | -116,1% | |
| 2025-12-22 | Anzalone Christopher Richard | Director, Officer, Chief Executive Officer | Open Market Sale | -2,574 | 68.85 | -177,219.90 | -30,1% | |
| 2025-12-19 | OLUKOTUN ADEOYE Y | Director | Open Market Sale | -827 | 68.48 | -56,632.96 | -9,6% | |
| 2025-12-19 | Anzalone Christopher Richard | Director, Officer, Chief Executive Officer | Open Market Sale | -3,979 | 66.67 | -265,279.93 | -45,0% | |
| 2025-12-19 | Anzalone Christopher Richard | Director, Officer, Chief Executive Officer | Open Market Sale | -8,147 | 68.01 | -554,077.47 | -94,0% | |
| 2025-12-19 | Anzalone Christopher Richard | Director, Officer, Chief Executive Officer | Open Market Sale | -1,319 | 68.48 | -90,325.12 | -15,3% | |
| 2025-12-19 | Anzalone Christopher Richard | Director, Officer, Chief Executive Officer | Open Market Sale | -3,979 | 66.67 | -265,279.93 | -45,0% | |
| 2025-12-19 | Anzalone Christopher Richard | Director, Officer, Chief Executive Officer | Open Market Sale | -8,147 | 68.01 | -554,077.47 | -94,0% | |
| 2025-12-19 | Anzalone Christopher Richard | Director, Officer, Chief Executive Officer | Open Market Sale | -1,319 | 68.48 | -90,325.12 | -15,3% | |
| 2025-12-19 | Waddill William D. | Director | Open Market Sale | -2,416 | 66.66 | -161,050.56 | -27,3% | |
| 2025-12-19 | Waddill William D. | Director | Open Market Sale | -5,451 | 68.01 | -370,722.51 | -62,9% | |
| 2025-12-19 | Waddill William D. | Director | Open Market Sale | -500 | 68.53 | -34,265.00 | -5,8% | |
| 2025-12-19 | Waddill William D. | Director | Open Market Sale | -2,416 | 66.66 | -161,050.56 | -27,3% | |
| 2025-12-19 | Waddill William D. | Director | Open Market Sale | -5,451 | 68.01 | -370,722.51 | -62,9% | |
| 2025-12-19 | Waddill William D. | Director | Open Market Sale | -500 | 68.53 | -34,265.00 | -5,8% | |
| 2025-12-19 | Vakiener Victoria | Director | Open Market Sale | -2,799 | 66.63 | -186,497.37 | -31,7% | |
| 2025-12-19 | Vakiener Victoria | Director | Open Market Sale | -5,281 | 67.97 | -358,949.57 | -60,9% | |
| 2025-12-19 | Vakiener Victoria | Director | Open Market Sale | -1,960 | 68.39 | -134,044.40 | -22,8% | |
| 2025-12-19 | Vakiener Victoria | Director | Open Market Sale | -2,799 | 66.63 | -186,497.37 | -31,7% | |
| 2025-12-19 | Vakiener Victoria | Director | Open Market Sale | -5,281 | 67.97 | -358,949.57 | -60,9% | |
| 2025-12-19 | Vakiener Victoria | Director | Open Market Sale | -1,960 | 68.39 | -134,044.40 | -22,8% | |
| 2025-12-19 | OLUKOTUN ADEOYE Y | Director | Open Market Sale | -3,090 | 66.70 | -206,103.00 | -35,0% | |
| 2025-12-19 | OLUKOTUN ADEOYE Y | Director | Open Market Sale | -6,083 | 68.04 | -413,887.32 | -70,2% | |
| 2025-12-19 | OLUKOTUN ADEOYE Y | Director | Open Market Sale | -827 | 68.48 | -56,632.96 | -9,6% | |
| 2025-12-19 | OLUKOTUN ADEOYE Y | Director | Open Market Sale | -3,090 | 66.70 | -206,103.00 | -35,0% | |
| 2025-12-19 | OLUKOTUN ADEOYE Y | Director | Open Market Sale | -6,083 | 68.04 | -413,887.32 | -70,2% | |
| 2025-12-17 | Anzalone Christopher Richard | Director, Officer, Chief Executive Officer | Open Market Sale | -46,287 | 63.55 | -2,941,538.85 | -499,2% | |
| 2025-12-17 | Anzalone Christopher Richard | Director, Officer, Chief Executive Officer | Open Market Sale | -982 | 65.53 | -64,350.46 | -10,9% | |
| 2025-12-17 | Anzalone Christopher Richard | Director, Officer, Chief Executive Officer | Open Market Sale | -1,981 | 66.30 | -131,340.30 | -22,3% | |
| 2025-12-17 | Anzalone Christopher Richard | Director, Officer, Chief Executive Officer | Open Market Sale | -46,287 | 63.55 | -2,941,538.85 | -499,2% | |
| 2025-12-17 | Anzalone Christopher Richard | Director, Officer, Chief Executive Officer | Open Market Sale | -1,981 | 66.30 | -131,340.30 | -22,3% | |
| 2025-12-17 | Anzalone Christopher Richard | Director, Officer, Chief Executive Officer | Open Market Sale | -982 | 65.53 | -64,350.46 | -10,9% | |
| 2025-12-17 | Anzalone Christopher Richard | Director, Officer, Chief Executive Officer | Open Market Sale | -35,750 | 64.51 | -2,306,232.50 | -391,4% | |
| 2025-12-17 | Anzalone Christopher Richard | Director, Officer, Chief Executive Officer | Open Market Sale | -35,750 | 64.51 | -2,306,232.50 | -391,4% | |
| 2025-12-16 | Anzalone Christopher Richard | Director, Officer, Chief Executive Officer | Open Market Sale | -8,476 | 62.94 | -533,479.44 | -90,5% | |
| 2025-12-16 | Anzalone Christopher Richard | Director, Officer, Chief Executive Officer | Open Market Sale | -1,000 | 64.96 | -64,960.00 | -11,0% | |
| 2025-12-16 | Anzalone Christopher Richard | Director, Officer, Chief Executive Officer | Open Market Sale | -166 | 66.77 | -11,083.82 | -1,9% | |
| 2025-12-16 | Anzalone Christopher Richard | Director, Officer, Chief Executive Officer | Open Market Sale | -1,300 | 65.77 | -85,501.00 | -14,5% | |
| 2025-12-16 | Anzalone Christopher Richard | Director, Officer, Chief Executive Officer | Open Market Sale | -3,221 | 67.87 | -218,609.27 | -37,1% | |
| 2025-12-16 | Anzalone Christopher Richard | Director, Officer, Chief Executive Officer | Open Market Sale | -1,000 | 64.96 | -64,960.00 | -11,0% | |
| 2025-12-16 | Anzalone Christopher Richard | Director, Officer, Chief Executive Officer | Open Market Sale | -8,416 | 60.51 | -509,252.16 | -86,4% | |
| 2025-12-16 | Anzalone Christopher Richard | Director, Officer, Chief Executive Officer | Open Market Sale | -14,095 | 62.12 | -875,581.40 | -148,6% | |
| 2025-12-16 | Anzalone Christopher Richard | Director, Officer, Chief Executive Officer | Open Market Sale | -10,963 | 61.25 | -671,483.75 | -114,0% | |
| 2025-12-16 | Anzalone Christopher Richard | Director, Officer, Chief Executive Officer | Open Market Sale | -8,416 | 60.51 | -509,252.16 | -86,4% | |
| 2025-12-16 | Anzalone Christopher Richard | Director, Officer, Chief Executive Officer | Open Market Sale | -10,963 | 61.25 | -671,483.75 | -114,0% | |
| 2025-12-16 | Anzalone Christopher Richard | Director, Officer, Chief Executive Officer | Open Market Sale | -14,095 | 62.12 | -875,581.40 | -148,6% | |
| 2025-12-16 | Anzalone Christopher Richard | Director, Officer, Chief Executive Officer | Open Market Sale | -6,661 | 64.29 | -428,235.69 | -72,7% | |
| 2025-12-16 | Anzalone Christopher Richard | Director, Officer, Chief Executive Officer | Open Market Sale | -3,221 | 67.87 | -218,609.27 | -37,1% | |
| 2025-12-16 | Anzalone Christopher Richard | Director, Officer, Chief Executive Officer | Open Market Sale | -166 | 66.77 | -11,083.82 | -1,9% | |
| 2025-12-16 | Anzalone Christopher Richard | Director, Officer, Chief Executive Officer | Open Market Sale | -1,300 | 65.77 | -85,501.00 | -14,5% | |
| 2025-12-16 | Anzalone Christopher Richard | Director, Officer, Chief Executive Officer | Open Market Sale | -6,661 | 64.29 | -428,235.69 | -72,7% | |
| 2025-12-16 | Anzalone Christopher Richard | Director, Officer, Chief Executive Officer | Open Market Sale | -8,476 | 62.94 | -533,479.44 | -90,5% | |
| 2025-12-15 | Anzalone Christopher Richard | Director, Officer, Chief Executive Officer | Open Market Sale | -100,532 | 68.67 | -6,903,532.44 | -1171,7% | |
| 2025-12-15 | Anzalone Christopher Richard | Director, Officer, Chief Executive Officer | Open Market Sale | -21,321 | 69.28 | -1,477,118.88 | -250,7% | |
| 2025-12-15 | Anzalone Christopher Richard | Director, Officer, Chief Executive Officer | Open Market Sale | -8,147 | 69.96 | -569,964.12 | -96,7% | |
| 2025-12-15 | Anzalone Christopher Richard | Director, Officer, Chief Executive Officer | Open Market Sale | -21,321 | 69.28 | -1,477,118.88 | -250,7% | |
| 2025-12-15 | Anzalone Christopher Richard | Director, Officer, Chief Executive Officer | Open Market Sale | -8,147 | 69.96 | -569,964.12 | -96,7% | |
| 2025-12-15 | Anzalone Christopher Richard | Director, Officer, Chief Executive Officer | Open Market Sale | -100,532 | 68.67 | -6,903,532.44 | -1171,7% | |
| 2025-12-05 | PERRY MICHAEL S | Director | Open Market Sale | -16,250 | 61.03 | -991,737.50 | -168,3% | |
| 2025-12-05 | PERRY MICHAEL S | Director | Open Market Sale | -16,250 | 61.03 | -991,737.50 | -168,3% | |
| 2025-11-28 | Ferrari Mauro | Director | Open Market Sale | -8,750 | 56.39 | -493,412.50 | -83,7% | |
| 2025-11-28 | Ferrari Mauro | Director | Open Market Sale | -8,750 | 56.39 | -493,412.50 | -83,7% | |
| 2025-10-01 | Hamilton James C | Officer, Chief Medical Officer | Open Market Sale | -20,000 | 35.00 | -700,000.00 | -118,8% | |
| 2025-10-01 | Hamilton James C | Officer, Chief Medical Officer | Open Market Sale | -20,000 | 35.00 | -700,000.00 | -118,8% | |
| 2025-09-12 | Hamilton James C | Officer, Chief Medical Officer | Open Market Sale | -15,000 | 30.00 | -450,000.00 | -76,4% | |
| 2025-09-12 | Hamilton James C | Officer, Chief Medical Officer | Open Market Sale | -15,000 | 30.00 | -450,000.00 | -76,4% | |
| 2025-09-02 | Hamilton James C | Officer, Chief Medical Officer | Open Market Sale | -15,000 | 25.00 | -375,000.00 | -63,6% | |
| 2025-09-02 | Hamilton James C | Officer, Chief Medical Officer | Open Market Sale | -15,000 | 25.00 | -375,000.00 | -63,6% | |
| 2025-08-15 | Hamilton James C | Officer, Chief Medical Officer | Open Market Sale | -9,389 | 20.00 | -187,780.00 | -31,9% | |
| 2025-08-15 | Hamilton James C | Officer, Chief Medical Officer | Open Market Sale | -9,389 | 20.00 | -187,780.00 | -31,9% | |
| 2025-08-13 | Hamilton James C | Officer, Chief Medical Officer | Open Market Sale | -611 | 20.00 | -12,220.00 | -2,1% | |
| 2025-08-13 | Hamilton James C | Officer, Chief Medical Officer | Open Market Sale | -611 | 20.00 | -12,220.00 | -2,1% | |
| 2025-04-11 | Anzalone Christopher Richard | Director, Officer, Chief Executive Officer | Open Market Sale | -50,800 | 11.49 | -583,692.00 | -99,1% | |
| 2025-04-11 | Anzalone Christopher Richard | Director, Officer, Chief Executive Officer | Open Market Sale | -50,800 | 11.49 | -583,692.00 | -99,1% | |
| 2025-04-10 | Anzalone Christopher Richard | Director, Officer, Chief Executive Officer | Open Market Sale | -50,000 | 10.87 | -543,500.00 | -92,2% | |
| 2025-04-10 | Anzalone Christopher Richard | Director, Officer, Chief Executive Officer | Open Market Sale | -50,000 | 10.87 | -543,500.00 | -92,2% | |
| 2025-04-09 | Anzalone Christopher Richard | Director, Officer, Chief Executive Officer | Open Market Sale | -3,400 | 10.75 | -36,550.00 | -6,2% | |
| 2025-04-09 | Anzalone Christopher Richard | Director, Officer, Chief Executive Officer | Open Market Sale | -1,617 | 11.76 | -19,015.92 | -3,2% | |
| 2025-04-09 | Anzalone Christopher Richard | Director, Officer, Chief Executive Officer | Open Market Sale | -35,305 | 9.93 | -350,578.65 | -59,5% | |
| 2025-04-09 | Anzalone Christopher Richard | Director, Officer, Chief Executive Officer | Open Market Sale | -3,400 | 10.75 | -36,550.00 | -6,2% | |
| 2025-04-09 | Anzalone Christopher Richard | Director, Officer, Chief Executive Officer | Open Market Sale | -1,617 | 11.76 | -19,015.92 | -3,2% | |
| 2025-04-09 | Anzalone Christopher Richard | Director, Officer, Chief Executive Officer | Open Market Sale | -35,305 | 9.93 | -350,578.65 | -59,5% |
Top-Fondshalter (aktuelles Quartal)
Keine Fondsdaten für das aktuelle Quartal vorhanden.